title: Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.
authors.affiliation: Department of Internal Medicine, Division of Hematology and Oncology, Michigan State University, East Lansing, MI, USA.
authors.forename: Ganapathy
authors.initials: G
authors.lastname: Krishnan
authors.forename: Karl
authors.initials: K
authors.lastname: D'Silva
authors.forename: Anas
authors.initials: A
authors.lastname: Al-Janadi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab